Clinical Trials Browser

OTHER × Hodgkin Disease × Histone Deacetylase Inhibitors × Clear all

NCT01460940 2017-11-14

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2 Completed

24 enrolled 7 charts

Hodgkin Disease